해외 임상시험 정보 데이터(GlobalData) 보고서 업데이트 안내 8.14. (수)

 

구분	보고서(영문)
제약/바이오/ 임상 시험(7건)	Bio/Pharmaceutical Outsourcing Report, July 2024
	Revenue Growth for 13 of Top 20 Biopharma Companies With Obesity Drug Successes in 2023
	Casgevy: Launch Sequence and Price Analysis of the First Marketed CRISPR Therapy
	Pfizer’s Hemophilia A Gene Therapy Shows Promise, but Tough Rivals Ahead
	FINEARTS-HF Trial Highlights Kerendia’s Potential to Differentiate in HF Space
	Adaptimmune Poised to Be a Market Leader in Soft Tissue Sarcoma Treatment with First TCR Approval
	Madrigal Plans to Solidify Rezdiffra’s Position in MASH Despite Start Being Slower Than Expected
컨퍼런스/심포지엄/ 학회/기타 (5건)	Global Risk Report (Quarterly Update) Q2 2024
	Contract Service Agreements – July 2024
	July Quarterly Contract Manufacturing Mergers, Acquisitions, and Financing – Q2 2024
	Contract Manufacturing: Opportunities and Threats – July 2024
	M&A in the Contract Manufacturing Industry: Implications and Outlook - 2024 Edition
질환별 (5건)	Recent Drug Approvals for Atopic Dermatitis to Contribute to Treatment Management
	Attention Deficit Hyperactivity Disorder (ADHD): Opportunity Assessment and Forecast
	Study Shows Insurance Instability Among Opioid Use Disorder Patients
	Chronic Urticaria: Competitive Landscape
	Spinal Muscular Atrophy: From Genes to Global Awareness